Cargando…
Conditionally Reprogrammed Cells and Robotic High-Throughput Screening for Precision Cancer Therapy
Cancer is a devastating disease that takes the lives of millions of people globally every year. Precision cancer therapy is based on a patient’s tumor histopathology, expression analyses, and/or tumor RNA or DNA analysis. Only 2%–20% of patients with solid tumors benefit from genomics-based precisio...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560709/ https://www.ncbi.nlm.nih.gov/pubmed/34737964 http://dx.doi.org/10.3389/fonc.2021.761986 |